OvaScience To Host Conference Call And Webcast Presentation With IVF Specialists To Review Early AUGMENT Fertility Treatment Patient Experience

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today a conference call focused on the AUGMENTSM treatment on Friday, March 27, 2015 at 10:00 am ET. The presentation will follow an AUGMENT treatment presentation at the Society for Reproductive Investigation (SRI) 62nd Annual Scientific Meeting, which represents the first time detailed clinical experience will be presented.

Help employers find you! Check out all the jobs and post your resume.